BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » News
Islet inflammation in plain sight

Islet inflammation in plain sight

Posted in: Publication|September 28, 2013

The exact cause of either type 1 or type 2 diabetes still remains unknown. Inflammation of the insulin-producing islets of Langerhans seems to be one of the common denominators during the early stage of both diseases. InSight Technology is a promising analytical tool for studying the inflammation processes. The review is published in Diabetes, Obesity …

Read more »
Apolipoprotein CIII hyperactivates insulin producing beta cells

Apolipoprotein CIII hyperactivates insulin producing beta cells

Posted in: Publication|August 15, 2013

Signal transduction between the diabetogenic blood factor apolipoprotein CIII (apoCIII) and insulin-producing beta cells is now clarified. ApoCIII acts upon the calcium channels through kinases PKA and Src, involving a receptor SR-BI and an integrin beta1. The results are published in Cellular and Molecular Life Sciences on the 15th of August 2013.   Calcium is very …

Read more »
InSight Technology in JOVE

InSight Technology in JOVE

Posted in: Publication|March 15, 2013

Advantages of and protocols for using InSight Technology as an imaging platform are presented in the March 2013 issue of the Journal of Visualized Experiments. Intravital, performed in the living organism, imaging has become an important tool in life sciences. A number of different technologies have emerged over the years and have been adapted to …

Read more »
You are what you eat – do not blame your mother

You are what you eat – do not blame your mother

Posted in: Publication|January 15, 2013

Researchers in Professor P-O Berggren’s group proposed utilizing InSight Technology to answer questions of islet development during infancy and puberty and to describe a ”point-of-no-return” for islet development programming. The commentary is published in Molecular Metabolism in January 2013. Genes and obesity are two major factors that contribute to the development of type 2 diabetes …

Read more »
Professor Berggren’s distinctions 2012

Professor Berggren’s distinctions 2012

Posted in: Company news, Society|January 3, 2013

Professor Per-Olof Berggren has received 4 major distinctions during 2012:  Alex Hirsch from Karolinska Institutet, Wallenberg Scholars, The Novo Nordisk Foundation Advanced Grant and Kroc Lecture at Boston University Medical Center. Professor Berggren’s distinctions are for the following achievements: Axel Hirsch Prize from Karolinska Institutet. The prize is for scientific achievements, which are potentially of major significance to the treatment of …

Read more »
Autonomic innervation of beta-cells in InSight

Autonomic innervation of beta-cells in InSight

Posted in: Publication|December 11, 2012

Blood glucose levels are controlled by the autonomous nervous system. Parasympathetic axons directly influence islet function, leading to higher insulin release and lower levels of blood glucose. The results are published in December 2012 in PNAS. The autonomous nervous system responsible for the unconscious regulation consists of parasympathetic and sympathetic parts, managing the calm and …

Read more »
Glucagone regulates its own synthesis

Glucagone regulates its own synthesis

Posted in: Publication|December 4, 2012

Once a hormone is released it can stimulate its own production. This principle was previously proven by Professor Berggren’s group in relation to insulin. Now the same group shows the generality of the approach: glucagon secreting cells increase their production when they sense increasing levels of glucagon. The results are published in PNAS in December …

Read more »
Biocrine featured in NyTeknik

Biocrine featured in NyTeknik

Posted in: Company news, Society|November 14, 2012

Biocrine’s CEO Professor PO Berggren was interviewed by NyTeknik, Swedish leading technology and IT newspaper. Treating diabetes with transplanted insulin-producing islets of Langerhans was the main subject of the discussion. Transplantation into the eye is a novel method developed by Prof Berggren’s research group. So far, the procedure has been thoroughly tested in mice leading …

Read more »
The pancreatic islet as a signaling hub

The pancreatic islet as a signaling hub

Posted in: Publication|September 28, 2012

The researchers in Professor Berggren’s group are in the forefront of resolving key challenges in understanding the molecular signalling in the islets of Langerhans, the endocrine pancreas. Specification of differences between human and mouse islet architecture and function as well as possibility to image molecular processes in the living organism will eventually lead to insights …

Read more »
The beta cell as a paradigm for advances in inositide research

The beta cell as a paradigm for advances in inositide research

Posted in: Uncategorized|September 20, 2012

Inositides are involved in regulating the insulin release from the pancreatic beta cell. New findings are published in Advances in Biological Regulation in September 2012. Inositides take an active part in regulating many vital processes in all cells in the organism. Depending on its primary function, cells have a specific footprint of what inositides they …

Read more »
« First«...5678»

Categories

Recent posts

  • Professor Berggren’s research publications
    Professor Berggren’s research publications September 1, 2026
  • RNA Technology Improves Islet Transplantation Outcomes
    RNA Technology Improves Islet Transplantation Outcomes August 27, 2026
  • Årsstämma 29 juni 2026
    Årsstämma 29 juni 2026 June 13, 2026
  • Framsteg för stamcellsterapi vid typ 1-diabetes
    Framsteg för stamcellsterapi vid typ 1-diabetes May 13, 2026
  • Western diet can cause permanent pancreatic damage, new study finds
    Western diet can cause permanent pancreatic damage, new study finds June 13, 2025
  • Årsstämma 26 juni 2025
    Årsstämma 26 juni 2025 June 10, 2025
  • Årsstämma 17 juni 2024
    Årsstämma 17 juni 2024 June 2, 2024
  • Researchers use the eye as a window to study liver health
    Researchers use the eye as a window to study liver health February 8, 2024
  • ERC Proof of Concept to Professor Per-Olof Berggren
    ERC Proof of Concept to Professor Per-Olof Berggren February 7, 2024
  • The anterior chamber of the eye as a servant to medical research in translation
    The anterior chamber of the eye as a servant to medical research in translation February 7, 2024

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved